Researchers have found that combining tolerogenic dendritic cells with Dimethyl Fumarate improves treatment efficacy for ...

Evidence is rising in favor of using highly effective DMTs to treat pediatric MS, but with few licensed for pediatric use, it ...

Medications are the mainstay of treatment for multiple sclerosis (MS). Many of them are used to block the immune system's attack on the nerves and slow or prevent progression and relapses (flare-ups) ...

A sublingual formulation of cladribine showed comparable pharmacological properties to its name brand counterpart, Mavenclad.

If you've been diagnosed with multiple sclerosis (MS), it's time to start exploring treatment options. You've got a lot of them, everything from disease-modifying therapies and drugs that help manage ...

Unjustified fears about harm in pregnancy is preventing the use of highly effective medications in women with MS, new ...

Results of a world-first phase 3 trial for secondary progressive multiple sclerosis (MS), led by UCL researchers, have shown ...

Rituximab and ocrelizumab, two drugs often used to treat multiple sclerosis (MS), may be useless for people with th ...

In people with primary progressive multiple sclerosis (MS), a new study has found no difference in the amount of time before ...

Multiple sclerosis (MS) is a debilitating autoimmune disease of the brain and spinal cord. The disease can affect everyone differently, but depending on th | Immunology ...

New treatments for promoting nerve cells regrowth in people with MS are inviting optimism at the University of Saskatchewan.